N/A N=57 Base-in Prism Spectacles for Intermittent Exotropia
Exotropia Intermittent
Primary: Exotropia Control Score at Distance, Continuous Score — 3.6; 3.3 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=65 Physiological Augmentation of Mindfulness Meditation
Post Traumatic Stress Disorder
Primary: Multiscale Dissociation Inventory (MDI) Score — 53.19; 61.58; 47.15; 51.00 score on a scale
Phase 2 N=52 Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients
Multiple Myeloma
Primary: Induction Feasibility Rate (IFR) — 33 Participants
Phase 4 N=43 Unilateral TAP Block for Laparoscopic Gastric Sleeve Surgery
Laparoscopic Sleeve Gastrectomy · Subcostal Transversus Abdominis Plane Block
Primary: Amount of 24 Hour Opioid Consumption — 44.7; 38.7 morphine milligram equivalents
N/A N=110 mHealth-supported Telecolposcopy for Cervical Cancer Programs in Low-resource Settings: Evaluation (mIVAA)
Cervical Cancer
Primary: Percentage of Women Referred to a Follow up Screening Appointment With a Colposcopist Who Did Not Attend the Appointment — 82.4 percentage of women
N/A N=15 Effects of Passive Heat Therapy on Oxygen Consumption and Cardiovascular Fitness in Adults
Heart Failure · Heart Diseases · Cardiovascular Diseases
Primary: Change in Blood Pressure — -2.94; 0.85 mmHg
Phase 2 N=120 Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis
Allergic Conjunctivitis
Primary: Ocular Itching at 5, 7, and 10 Minutes Post CAC on Day 1 — 2.573; 2.500; 1.217; 2.647 units on a scale
Phase 1 N=31 Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma
Asthma
Primary: Maximum Percentage Decrease in Forced Expiratory Volume in 1 Second (FEV1) at 3 to 7 Hours Post Allergen Challenge — -20.645; -16.949; -19.366; -12.064 percent change…
Phase 2 N=57 Controlled Trial Evaluating Avacopan in C3 Glomerulopathy
C3 Glomerulopathy (C3G)
Primary: Change From Baseline to Week 26 in the C3G Histologic Index for Disease Activity - Subjects With Elevated C5b-9 — -0.9; -1.0 score on a scale — p=0.9670
N/A N=116 Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy
Lung Cancer
Primary: Number of Participants With Overall Survival (OS) at 3 Years — 31; 70 Participants
Phase 2 N=162 Facilitating Smoking Cessation With Reduced Nicotine Cigarettes
Smoking Cessation
Primary: Study 1 - Rate of Participant Completion of Pilot — 4; 5 Participants
N/A N=30 TOSS Feasibility + Fitbit Community = Reduced Obesity in Older Black Women
Obesity
Primary: Change in Physical Activity Behaviors From Baseline to 12 Weeks — -736.71; 218.79 change in daily steps (baseline - post) — p=<0.05
Phase 3 N=419 Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)
Chronic Cough
Primary: Change From Baseline in the Leicester Cough Questionnaire (LCQ) Total Score at Week 12 — 4.34; 3.59 Scores on a Scale — p=0.034
Phase 3 N=156 Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action
Alcohol Use Disorder
Primary: Number of Drinks Per Week — 19.7; 23.7 Number of drinks per week — p=0.0130
N/A N=456 Safety and Effectiveness Study of the Reflection Ceramic Acetabular System
Osteoarthritis
Primary: Survival of Hip Implant Based on Number of Hips Requiring Revision — 12; 9; 2; 1 Hips